Literature DB >> 4069864

Muscle involvement in progressive diaphyseal dysplasia.

Y Naveh, R Ludatshcer, U Alon, B Sharf.   

Abstract

Muscle involvement in progressive diaphyseal dysplasia was evaluated in five children, of whom four were members of one family. Age range was 2 to 10 years 9 months, and mean age was 5.5 years. Evaluation included serum enzymes, electromyography, and muscle biopsy examined by light and electron microscopy. Serum enzymes were usually noncontributory. Electromyography revealed "myopathic pattern" in four of the five patients. Muscle biopsy specimens were taken from three of the five children, including two patients from one family, of whom one had normal electromyography, and one sporadic case. Examination of the biopsy specimens by light microscope was generally not useful, whereas electron microscopic examination revealed myopathic and vascular changes consisting of atrophy of isolated muscle fibers, accumulation of endomysial collagen fibrils, and thickening of the perivascular basement membrane. The main contribution of this study is to describe electron microscopic vascular changes in muscles that appear to be similar in familial and sporadic cases of progressive diaphyseal dysplasia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4069864

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  3 in total

1.  Vecuronium was safely used in a patient with Engelmann's disease without muscle weakness.

Authors:  Koji Sato; Maiko Nakajima; Tetsu Kimura; Toshiaki Nishikawa
Journal:  J Anesth       Date:  2012-01-15       Impact factor: 2.078

2.  Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3.

Authors:  M Ghadami; Y Makita; K Yoshida; G Nishimura; Y Fukushima; K Wakui; S Ikegawa; K Yamada; S Kondo; N Niikawa; H a Tomita
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Progressive diaphyseal dysplasia masquerading as shoulder capsulitis in an adult.

Authors:  D Schapira; D Militeanu; O Israel; I Misselevich; Y Scharf
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.